期刊文献+

胃癌组织Cox-2和MMP-2与MMP-9蛋白表达及其临床意义的研究 被引量:13

Expressions and clinical significance of Cox-2,MMP-2 and MMP-9 proteins in human gastric carcinoma
下载PDF
导出
摘要 目的:探讨Cox-2、MMP-2及MMP-9蛋白在胃癌中表达、相互关系及临床意义。方法:采用免疫组化SP法检测96例胃癌组织及癌旁正常组织Cox-2、MMP-2和MMP-9蛋白表达。结果:胃癌组织中Cox-2、MMP-2及MMP-9阳性表达率分别为74.0%(71/96)、72.9%(70/96)及66.7%(64/96),皆明显高于癌旁正常组织(Cox-2、MMP-2及MMP-9阳性表达率分别为32.3%、30.2%和31.3%),P<0.001;三者的表达都与肿瘤发生部位、肿瘤浸润深度、临床分期及淋巴结转移呈明显的正相关,P<0.05,而与患者年龄、性别、肿瘤大小和分化程度无显著相关性,P>0.05;Cox-2与MMP-2、MMP-9蛋白表达呈明显的正相关性。结论:胃癌组织中存在Cox-2、MMP-2及MMP-9蛋白的高表达,Cox-2与MMP-2和MMP-9蛋白表达强度具有等级相关性。Cox-2蛋白可通过诱导MMP-2和MMP-9蛋白的表达上调,增加胃癌细胞的侵袭力,从而成为其促进胃癌浸润和转移的途径之一。 OBJECTIVE:To study the expressions and clinical significance of Cox-2,MMP-2 and MMP-9 proteins and their relationships with human gastric carcinoma.METHODS:Cox-2,MMP-2 and MMP-9 protein expressions were examined by immunohistochemistry in 96 cases of human gastric carcinoma and paracancerous normal tissues.RESULTS:The expression rates of Cox-2,MMP-2 and MMP-9 in gastric carcinoma tissues were 74.0%(71/96),72.9%(70/96)and 66.7%(64/96)respectively,which were significantly higher than those in paracancerous no...
出处 《中华肿瘤防治杂志》 CAS 2008年第13期1003-1006,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 胃肿瘤/病理学 环氧化酶-2 金属蛋白酶-2 金属蛋白酶-9 免疫组织化学 gastric neoplasms/pathology cyclooxygenase-2 matrix metalloproteinase-2 matrix metalloproteinase-9 immunohistochemistry
  • 相关文献

参考文献4

二级参考文献119

  • 1[1]Harrison LE,Choe JK,Goldstein M,Meridian A,Kim SH,Clarke K.Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients.J Surg Oncol 2000; 73:153-157
  • 2[2]Saragoni L,Gaudio M,Morgagni P,Folli S,Bazzocchi F,Scarpi E,Saragoni A.Identification of occult micrometastases in patients with early gastric cancer using anti-cytokeratin monoclonal antibodies.Oncol Rep 2000; 7:535-539
  • 3[3]Nakajo A,Natsugoe S,Ishigami S,Matsumoto M,Nakashima S,Hokita S,Baba M,Takao S,Aikou T.Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer.Ann Surg Oncol 2001; 8:158-162
  • 4[4]Morgagni P,Saragoni L,Folli S,Gaudio M,Scarpi E,Bazzocchi F,Marra GA,Vio A.Lymph node micrometastases in patients with early gastric cancer:experience with 139 patients.Ann Surg Oncol 2001; 8:170-174
  • 5[5]Lee E,Chae Y,Kim I,Choi J,Yeom B,Leong AS.Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma.Cancer 2002;94:2867-2873
  • 6[6]Choi HJ,Kim YK,Kim YH,Kim SS,Hong SH.Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma.Ann Surg Oncol 2002; 9:13-19
  • 7[7]Yasuda K,Adachi Y,Shiraishi N,Inomata M,Takeuchi H,Kitano S.Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer.Ann Surg Oncol 2002; 9:771-774
  • 8[8]Ajisaka H,Miwa K.Micrometastases in sentinel nodes of gastric cancer.Br J Cancer 2003; 89:676-680
  • 9[9]Higashi H,Natsugoe S,Ishigami S,Uenosono Y,Matsumoto M,Nakajo A,Miyazono F,Hokita S,Takao S,Aikou T.Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion.World J Surg 2003;27:455-459
  • 10[10]Karube T,Ochiai T,Shimada H,Nikaidou T,Hayashi H.Detection of sentinel lymph nodes in gastric cancers based on immunohistochemical analysis of micrometastases.J Surg Oncol 2004; 87:32-38

共引文献73

同被引文献143

引证文献13

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部